FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060704373> ?p ?o ?g. }

• W2060704373 endingPage "1649" @default.
• W2060704373 startingPage "1644" @default.
• W2060704373 abstract "The aim of the study was to assess the toxicity and the clinical activity of biweekly oxaliplatin in combination with infusional 5-fluorouracil (5-FU) and folinic acid (FA) administered every 2 weeks (FOLFOX-4 regimen) in patients with advanced gastric cancer (AGC). A total of 61 previously untreated AGC patients were treated with oxaliplatin 85 mg m(-2) on day 1, FA 200 mg m(-2) as a 2 h infusion followed by bolus 5-FU 400 mg m(-2) and a 22 h infusion of 5-FU 600 mg m(-2), repeated for 2 consecutive days every 2 weeks. All patients were assessable for toxicity and response to treatment. Four (7%) complete responses and 19 partial responses were observed (overall response rate, 38%). Stable disease was observed in 22 (36%) patients, with progressive disease in the other six (10%) patients. Median time to progression (TTP) and median overall survival (OS) were 7.1 and 11.2 months, respectively. National Cancer Institute Common Toxicity Criteria grade 3 and 4 haematologic toxicities were neutropenia, anaemia and thrombocytopenia in 36, 10 and 5% of the patients, respectively. Grade 3 peripheral neuropathy was recorded in three (5%) patients. FOLFOX-4 is an active and well-tolerated chemotherapy. Response rate (RR), TTP and OS were comparable with those of other oxaliplatin-based regimens, suggesting a role for this combination in gastric cancer." @default.
• W2060704373 created "2016-06-24" @default.
• W2060704373 creator A5009130863 @default.
• W2060704373 creator A5010462154 @default.
• W2060704373 creator A5014577156 @default.
• W2060704373 creator A5028284107 @default.
• W2060704373 creator A5028851538 @default.
• W2060704373 creator A5038057718 @default.
• W2060704373 creator A5040413764 @default.
• W2060704373 creator A5040445172 @default.
• W2060704373 creator A5047765884 @default.
• W2060704373 creator A5047814180 @default.
• W2060704373 creator A5049825933 @default.
• W2060704373 creator A5053448211 @default.
• W2060704373 creator A5056034569 @default.
• W2060704373 creator A5064816004 @default.
• W2060704373 creator A5068999228 @default.
• W2060704373 creator A5076081642 @default.
• W2060704373 creator A5078562748 @default.
• W2060704373 creator A5079728258 @default.
• W2060704373 date "2005-04-26" @default.
• W2060704373 modified "2023-10-16" @default.
• W2060704373 title "A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients" @default.
• W2060704373 cites W175148688 @default.
• W2060704373 cites W1843791750 @default.
• W2060704373 cites W1848862702 @default.
• W2060704373 cites W1937087099 @default.
• W2060704373 cites W1940613095 @default.
• W2060704373 cites W1968428706 @default.
• W2060704373 cites W1976651872 @default.
• W2060704373 cites W1982559524 @default.
• W2060704373 cites W1988820703 @default.
• W2060704373 cites W1992408996 @default.
• W2060704373 cites W1996167718 @default.
• W2060704373 cites W2023316407 @default.
• W2060704373 cites W2029409133 @default.
• W2060704373 cites W2035185002 @default.
• W2060704373 cites W2052457410 @default.
• W2060704373 cites W2059234543 @default.
• W2060704373 cites W2065895095 @default.
• W2060704373 cites W2065982243 @default.
• W2060704373 cites W2095256813 @default.
• W2060704373 cites W2121368761 @default.
• W2060704373 cites W2122731269 @default.
• W2060704373 cites W2123495698 @default.
• W2060704373 cites W2128775037 @default.
• W2060704373 cites W2130522735 @default.
• W2060704373 cites W2158245475 @default.
• W2060704373 cites W2288788326 @default.
• W2060704373 cites W2400830360 @default.
• W2060704373 doi "https://doi.org/10.1038/sj.bjc.6602573" @default.
• W2060704373 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2362040" @default.
• W2060704373 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15856038" @default.
• W2060704373 hasPublicationYear "2005" @default.
• W2060704373 type Work @default.
• W2060704373 sameAs 2060704373 @default.
• W2060704373 citedByCount "161" @default.
• W2060704373 countsByYear W20607043732012 @default.
• W2060704373 countsByYear W20607043732013 @default.
• W2060704373 countsByYear W20607043732014 @default.
• W2060704373 countsByYear W20607043732015 @default.
• W2060704373 countsByYear W20607043732016 @default.
• W2060704373 countsByYear W20607043732017 @default.
• W2060704373 countsByYear W20607043732018 @default.
• W2060704373 countsByYear W20607043732019 @default.
• W2060704373 countsByYear W20607043732020 @default.
• W2060704373 countsByYear W20607043732021 @default.
• W2060704373 countsByYear W20607043732022 @default.
• W2060704373 countsByYear W20607043732023 @default.
• W2060704373 crossrefType "journal-article" @default.
• W2060704373 hasAuthorship W2060704373A5009130863 @default.
• W2060704373 hasAuthorship W2060704373A5010462154 @default.
• W2060704373 hasAuthorship W2060704373A5014577156 @default.
• W2060704373 hasAuthorship W2060704373A5028284107 @default.
• W2060704373 hasAuthorship W2060704373A5028851538 @default.
• W2060704373 hasAuthorship W2060704373A5038057718 @default.
• W2060704373 hasAuthorship W2060704373A5040413764 @default.
• W2060704373 hasAuthorship W2060704373A5040445172 @default.
• W2060704373 hasAuthorship W2060704373A5047765884 @default.
• W2060704373 hasAuthorship W2060704373A5047814180 @default.
• W2060704373 hasAuthorship W2060704373A5049825933 @default.
• W2060704373 hasAuthorship W2060704373A5053448211 @default.
• W2060704373 hasAuthorship W2060704373A5056034569 @default.
• W2060704373 hasAuthorship W2060704373A5064816004 @default.
• W2060704373 hasAuthorship W2060704373A5068999228 @default.
• W2060704373 hasAuthorship W2060704373A5076081642 @default.
• W2060704373 hasAuthorship W2060704373A5078562748 @default.
• W2060704373 hasAuthorship W2060704373A5079728258 @default.
• W2060704373 hasBestOaLocation W20607043731 @default.
• W2060704373 hasConcept C121608353 @default.
• W2060704373 hasConcept C126322002 @default.
• W2060704373 hasConcept C141071460 @default.
• W2060704373 hasConcept C2776694085 @default.
• W2060704373 hasConcept C2777063308 @default.
• W2060704373 hasConcept C2778260052 @default.
• W2060704373 hasConcept C2779804826 @default.
• W2060704373 hasConcept C2780456651 @default.
• W2060704373 hasConcept C2780962732 @default.

• next